microPublication

Get Your Data Out, Be Cited

  • About
    • Editorial Policies
      • Editorial Staff
      • Editorial Board
      • Criteria For Publication
      • Publishing Information
      • Data Sharing Policy
    • For Authors
      • Preparation And Submission Of A Manuscript
      • Peer Review Process
      • Following Acceptance
      • Appeals
    • For Reviewers
    • Why micropublish?
  • Submit a microPublication
  • Journals
    • microPublication Biology
      • Editorial Board
  • microPublications
    • Biology
      • Species
        • Arabidopsis
        • C. elegans
        • D. discoideum
        • Drosophila
        • Human
        • Mouse
        • S. cerevisiae
        • S. pombe
        • Xenopus
        • Zebrafish
      • Categories
        • Phenotype Data
        • Methods
        • Expression Data
        • Genotype Data
        • Integrations
        • Genetic Screens
        • Models of Human Disease
        • Software
        • Interaction data
        • Database Updates
        • Electrophysiology Data
        • Phylogenetic Data
        • Science and Society
        • Biochemistry
  • Contact
  • More
    • Archives
    • FAQs
    • Newsletter
microPublication / Biology / Serum-free adapted Drosophila S2R+ line...
Serum-free adapted Drosophila S2R+ line is amenable to RNA interference
Arthur Luhur1,2,3, Daniel Mariyappa1,2,3, Kristin M Klueg1,2,3, Stephen L Rogers2,4 and Andrew C Zelhof1,2,3
1Drosophila Genomics Resource Center
2Department of Biology
3Indiana University
4The University of North Carolina, Chapel Hill
Correspondence to: Andrew C Zelhof (azelhof@indiana.edu)

Abstract

We have previously adapted a select number of Drosophila cell lines to grow in serum-free media supplemented with fly extract. This condition is arguably more representative of a native growth environment. Here, we validated that the fly extract adapted line, S2R+ (FEx 2.5%) is amenable to RNAi. RNAi against Rho1 in both S2R+ and S2R+ (FEx 2.5%) produced phenotypes similar to ones previously described in Drosophila S2 cells.

Figure 1: A-D. Light micrographs of S2R+ and S2R+ (FEx 2.5 %) cells. S2R+ cells cultured in M3 + BPYE + 10% FBS (A,B) were treated with either dsRNA against cat (A) or dsRNA against Rho1 (B). S2R+ (FEx 2.5%) cells cultured in M3 + 2.5% FEx (C,D) were treated with either dsRNA against cat (C) or dsRNA against Rho1 (D). Scale bar = 10 micrometers. E-H Fluorescence confocal images of S2R+ cells and S2R+ (FEx 2.5%) cells. S2R+ cells cultured in M3 + BPYE + 10% FBS (E,F) were treated with either dsRNA against cat (E) or dsRNA against Rho1 (F). S2R+ (FEx 2.5%) cells cultured in M3 + 2.5% FEx (G,H) were treated with either dsRNA against cat (G) or dsRNA against Rho1 (H). * marks an enlarged and multi-nucleated cell. DAPI (purple) marks the DNA and phalloidin (green) marks cytoskeletal actin. Scale bar = 8 micrometers. I. A bar graph shows the ratio of cell numbers after seven days of RNAi treatment against Rho1 or cat, to the cell number on day 0. * denotes p < 0.05. J. Immunoblot of Rho1 and α-Tubulin from S2R+ and S2R+ (FEx 2.5%) cells, and treated with dsRNA against Rho1 or dsRNA against cat. α-tubulin serves as loading control.

Description

Drosophila Schneider S2 cell lines are susceptible to RNA interference (RNAi) and this attribute has cemented Drosophila cell lines as an important tool for high throughput functional genomics screening (Rogers and Rogers 2008; Zhou et al. 2013; Mohr 2014). RNAi against Drosophila Rho1 in S2 cells results in a block in mitosis, giving rise to enlarged and multinucleated cells (Rogers et al. 2004). Recently, we have adapted a select group of Drosophila embryonic cell lines to grow in media supplemented by adult fly extract (FEx), instead of fetal bovine serum (FBS) (Luhur et al. 2020). Here, we demonstrate that S2R+ (FEx 2.5%), the M3 + 2.5% FEx-adapted S2R+ line is also amenable to RNA interference (RNAi), similar to its parental S2R+ cells cultured in M3 BPYE + 10% FBS. We observed similar efficacious RNAi against Rho1 in S2R+ and S2R+ (FEx 2.5%) as the cells became enlarged (Figure 1A-D), multinucleated (Figure 1E-H) and failed to proliferate (Figure 1I). There was a comparable growth delay in S2R+ and S2R+ (FEx 2.5%) cells treated with Rho1 dsRNA, as the cell population doubled in 7 days (Figure 1I). In contrast, both S2R+ and S2R+ (FEx 2.5%) cells treated with double stranded RNA against a control target gene encoding the bacterial antibiotic resistance gene chloramphenicol acetyl transferase (cat) had significantly proliferated 5 fold more under similar conditions (Figure 1I). In addition, there were no significant differences in the growth ratio between S2R+ and S2R+ (FEx 2.5%) (Figure 1I) (Luhur et al. 2020). These results demonstrate that Rho1 RNAi was recapitulated robustly in S2R+ (FEx 2.5%), similar to its parental S2R+ cells. Lastly, to confirm the depletion of Rho1, we assayed for Rho1 protein levels in these cultures by Western blot. Our result indicated a strong reduction in the amount of Rho1 protein in both S2R+ (FEx 2.5%) and S2R+ cells after Rho1 knockdown (Figure 1J). In contrast, the control RNAi knockdown of cat did not affect Rho1 protein levels in either S2R+ or S2R+ (FEx 2.5%) (Figure 1J). In summary, this finding expands the utility of the fly extract-adapted cells for their use in functional genomics in a more physiologically relevant culture condition.

Methods

Request a detailed protocol

Cell culture

S2R+ (DGRC#150, FBtc0000150), S2R+ (FEx 2.5%) (DGRC#310, FBtc0000310) were cultured in M3 + BPYE + 10% FBS and M3 + 2.5% FEx, respectively, according to previously described protocol (Luhur et al. 2019).

RNA interference (RNAi)

Cells from the respective growth media were pelleted and then seeded at 1 million cells/ mL in serum free M3 media in a 24 well plate (1 mL per well). 10 mg/mL dsRNA was added slowly to the media and allowed to incubate at room temperature for 1 hour. After the incubation period, the M3 media was supplemented with equal volumes of either M3+BPYE+20% FBS or M3 + 5% FEx, to constitute the M3 + BPYE + 10% FBS and M3 + 2.5% FEx, respectively. Cells were allowed to grow for a week at 25°C before assaying for the loss of function phenotypes.

As a negative control, a 467-bp fragment of the chloramphenicol resistance cassette was amplified from pFastBacHT-CAT expression plasmid (Invitrogen) using the primers: T7-CAT-fwd: 5′-TAATACGACTCACTATAGGATCCCAATGGCATCGTAAAGAACATTTTGAGGC-3′ and T7-CAT-rev:
5′-TAATACGACTCACTATAGGGGGCGAAGAAGTTGTCCATATTGGCCA-3′.

As a positive control, we amplified a 667-bp sequence for Rho1(FBgn0014020) using the primers: T7-Rho1-fwd: 5′-TAATACGACTCACTATAGGTTTGTTTTGTGTTTAGTTCGGC-3′ and T7-Rho1-rev: 5′-TAATACGACTCACTATAGGATCAAGAACAACCAGAACATCG-3′, from a Rho1 expression construct, originally provided by Dr. Liqun Luo (Stanford University). The dsRNA synthesis protocols followed the protocol described (Rogers and Rogers 2008).

Immunostaining and microscopy

The cells were seeded on dishes coated with Concanavalin A. After one hour, the media was removed and the cells were fixed for 10 minutes in a solution containing 4% paraformaldehyde diluted in phosphate buffered saline (PBS). The cells were then rinsed in 0.1% PBS-Triton-X and incubated in 1:1000 phalloidin for two hours at room temperature. Subsequently, the cells were rinsed for three times in 0.1% PBS-Triton-X before being mounted on Vectashield mounting media containing DAPI (H-1300). Fluorescence imaging was carried out using the Leica SP8 confocal microscope.

Protein extraction and Western Blotting

Cell pellets from a single well of a 24-well plate cells subjected to RNAi against either Rho1 or cat (dsRNA control) were lysed with RIPA buffer. Proteins in the lysed samples were separated with a BioRad WGX 4-20% gel, transferred onto Nitrocellulose membrane (BioRad) and blotted with either mouse anti-Rho1 (p1D9, from Developmental Studies Hybridoma Bank deposited by Parkhurst, S) or mouse anti- α-tubulin (T9026, Sigma). The blots were treated with anti-mouse HRP and the signals were visualized using Pierce Enhanced Chemiluminescence Reagent (ThermoFisher). The experiment was conducted in duplicate.

Cell counting and statistical analysis

Live cells were counted using an automated cell counter (BIORAD) according to manufacturer’s instructions. Each condition had a total of three replicate counts. Statistical analysis of the differences in the growth ratio was carried out using Prism8 using ordinary-one way ANOVA test, with Sidak’s multiple comparison test.

Acknowledgments

The Rho1 antibody was procured from Developmental Studies Hybridoma Bank (University of Iowa, IA). We also acknowledge the Light Microscopy Imaging Center (LMIC) at Indiana University Bloomington.

References

Luhur A, Klueg KM, Roberts J, Zelhof AC. 2019. Thawing, Culturing, and Cryopreserving Drosophila Cell Lines. J Vis Exp. Apr 16;(146):10.3791/59459.
10.3791/59459 | PubMed
Luhur A, Mariyappa D, Klueg KM, Buddika K, Tennessen JM, Zelhof AC. 2020. Adapting Drosophila melanogaster Cell Lines to Serum-Free Culture Conditions. G3 (Bethesda) 10: 4541-4551.
PubMed
Mohr SE. 2014. RNAi screening in Drosophila cells and in vivo. Methods 68: 82-8.
PubMed
Rogers SL, Rogers GC. 2008. Culture of Drosophila S2 cells and their use for RNAi-mediated loss-of-function studies and immunofluorescence microscopy. Nat Protoc 3: 606-11.
PubMed
Rogers SL, Wiedemann U, Häcker U, Turck C, Vale RD. 2004. Drosophila RhoGEF2 associates with microtubule plus ends in an EB1-dependent manner. Curr Biol 14: 1827-33.
PubMed
Zhou R, Mohr S, Hannon GJ, Perrimon N. 2013. Inducing RNAi in Drosophila cells by transfection with dsRNA. Cold Spring Harb Protoc 2013: 461-3.
PubMed

Funding

This work was supported by a NIH grant (2P40OD010949) awarded to the Drosophila Genomics Resource Center.

Author Contributions

Arthur Luhur: Conceptualization, Methodology, Investigation, Writing - original draft, Writing - review and editing, Formal analysis, Visualization
Daniel Mariyappa: Formal analysis, Investigation, Visualization, Writing - review and editing
Kristin M Klueg: Writing - review and editing
Stephen L Rogers: Resources, Writing - review and editing
Andrew C Zelhof: Resources, Supervision, Writing - review and editing, Funding acquisition.

Reviewed By

Anonymous

History

Received: January 5, 2021
Revision received: January 22, 2021
Accepted: January 22, 2021
Published: January 29, 2021

Copyright

© 2021 by the authors. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Luhur, A; Mariyappa, D; Klueg, KM; Rogers, SL; Zelhof, AC (2021). Serum-free adapted Drosophila S2R+ line is amenable to RNA interference. microPublication Biology. 10.17912/micropub.biology.000362.
Download: RIS BibTeX
microPublication Biology is published by
1200 E. California Blvd. MC 1-43 Pasadena, CA 91125
The microPublication project is supported by
The National Institute of Health -- Grant #: 1U01LM012672-01
microPublication Biology:ISSN: 2578-9430